MOSPD2 is a therapeutic target for the treatment of CNS inflammation

In multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), myeloid cells comprise a major part of the inflammatory infiltrate in the central nervous system (CNS). We previously described that motile sperm domain‐containing protein 2 (MOSPD2) is expressed on human myeloid cells and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yacov, N., Kafri, P., Salem, Y., Propheta‐Meiran, O., Feldman, B., Breitbart, E., Mendel, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Editors' Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366745/
https://www.ncbi.nlm.nih.gov/pubmed/32353176
http://dx.doi.org/10.1111/cei.13448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366745/
https://www.ncbi.nlm.nih.gov/pubmed/32353176
http://dx.doi.org/10.1111/cei.13448

Ejemplares similares